These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 29416944)

  • 1. Mid-Term Assessment of the EU Drugs Strategy 2013-2020 and Final Evaluation of the Action Plan on Drugs 2013-2016: Final report.
    Emilie B; Matthew D; Emma D; Cristina Gonzalez M; Stephen H; Stijn H; Kristy K; Martin S; Jirka T
    Rand Health Q; 2018 Jan; 7(2):4. PubMed ID: 29416944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organ transplantation and the European Union, 2009-2015 developments.
    Van der Spiegel S; Schröder-Bäck P; Brand H
    Transpl Int; 2020 Jun; 33(6):603-611. PubMed ID: 32097506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The European Commission proposal for a marine strategy: lacking substance.
    Salomon M
    Mar Pollut Bull; 2006 Nov; 52(11):1328-9. PubMed ID: 16979670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
    Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
    Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tackling rare diseases at European level: why do we need a harmonized framework?
    Taruscio D; Trama A; Stefanov R
    Folia Med (Plovdiv); 2007; 49(1-2):59-67. PubMed ID: 18018471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Leap to Hybrid Governance for European Union Healthcare on Organ Donations.
    Ahmed T
    J Law Health; 2018; 31(1):118-144. PubMed ID: 30889336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a bioeconomy monitoring framework for the European Union: An integrative and collaborative approach.
    Robert N; Giuntoli J; Araujo R; Avraamides M; Balzi E; Barredo JI; Baruth B; Becker W; Borzacchiello MT; Bulgheroni C; Camia A; Fiore G; Follador M; Gurria P; la Notte A; Lusser M; Marelli L; M'Barek R; Parisi C; Philippidis G; Ronzon T; Sala S; Sanchez Lopez J; Mubareka S
    N Biotechnol; 2020 Nov; 59():10-19. PubMed ID: 32622862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. European Union implementation of Article 5.3 of the Framework Convention on Tobacco Control.
    Hawkins B; Holden C
    Global Health; 2018 Aug; 14(1):79. PubMed ID: 30071862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A critical evaluation of the European Drug Strategy: has it brought added value to drug policy making at the national level?
    Chatwin C
    Int J Drug Policy; 2013 May; 24(3):251-6. PubMed ID: 23238457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the implementation of the EU Drugs Strategy 2005-2012 and its Action Plans.
    Culley DM; Taylor J; Rubin J; Hoorens S; Disley E; Rabinovich L
    Rand Health Q; 2012; 2(2):15. PubMed ID: 28083256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review.
    Allen D; Gillen E; Rixson L
    JBI Libr Syst Rev; 2009; 7(3):80-129. PubMed ID: 27820426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Global Health Policies of the EU and its Member States: A Common Vision?
    Steurs L; Van de Pas R; Delputte S; Orbie J
    Int J Health Policy Manag; 2018 May; 7(5):433-442. PubMed ID: 29764107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pediatric drug development: ICH harmonized tripartite guideline E11 within the United States of America, the European Union, and Japan].
    Pflieger M; Bertram D
    Arch Pediatr; 2014 Oct; 21(10):1129-38. PubMed ID: 25175054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How should public health policy be developed? A case study in European public health.
    Birt CA; Gunning-Schepers L; Hayes A; Joyce L
    J Public Health Med; 1997 Sep; 19(3):262-7. PubMed ID: 9347448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strengthening and rationalizing pharmacovigilance in the EU: where is Europe heading to? A review of the new EU legislation on pharmacovigilance.
    Borg JJ; Aislaitner G; Pirozynski M; Mifsud S
    Drug Saf; 2011 Mar; 34(3):187-97. PubMed ID: 21332243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transposition and implementation of EU rare disease policy in Eastern Europe.
    Pejcic AV; Iskrov G; Raycheva R; Stefanov R; Jakovljevic MM
    Expert Rev Pharmacoecon Outcomes Res; 2017 Dec; 17(6):557-566. PubMed ID: 28975845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. European Union policy on smokeless tobacco: a statement in favour of evidence based regulation for public health.
    Bates C; Fagerström K; Jarvis MJ; Kunze M; McNeill A; Ramström L
    Tob Control; 2003 Dec; 12(4):360-7. PubMed ID: 14660767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health system performance assessment landscape at the EU level: a structured synthesis of actors and actions.
    Perić N; Hofmarcher-Holzhacker MM; Simon J
    Arch Public Health; 2017; 75():5. PubMed ID: 28163918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bread and butter or bread and circuses? Politicisation and the European Commission in the European Semester.
    van der Veer RA; Haverland M
    Eur Union Polit; 2018 Sep; 19(3):524-545. PubMed ID: 30220878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A concise overview of national nutrition action plans in the European Union Member States.
    Lachat C; Van Camp J; De Henauw S; Matthys C; Larondelle Y; Remaut-De Winter AM; Kolsteren P
    Public Health Nutr; 2005 May; 8(3):266-74. PubMed ID: 15918923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.